GLP1 agonists like Semaglutide, Liraglutide may increase risk of pancreatitis, gastroparesis and bowel obstruction US: Researchers at University of British Columbia have found in a new study that that use of glucagon-like peptide-1 agonists for weight loss compared with use of bupropion-naltrexone was associated with increased risk of pancreatitis, gastroparesis, and bowel obstruction but not biliary disease
Dietary Trimethylamine N-Oxide Exacerbates Impaired Glucose Tolerance in Mice Fed a High Fat Diet
Ozempic's reduced price available via NovoCare Pharmacy, GoodRx and Novo Nordisk's site
Metformin users, common among type 2 diabetes patients who then add semaglutide, face a double hit since metformin independently reduces B12 absorption by 10-30% over long-term use
COVID-19 Impact The COVID-19 pandemic has severely impacted the global economies with all the sectors witnessing a significant slump during 2020
Embracing Natural Paths to Wellness: The Pritikin Advantage In contrast to the pharmacological approach to weight loss, which can be marred by side effects, natural weight loss retreats like Pritikin offer a holistic and sustainable path to health and wellness